Lifecome Biochemistry Co.,Ltd. (SHE:002868)
China · Delayed Price · Currency is CNY 18.85
+0.56 (3.06%)
Nov 5, 2026, 3:04 PM CST
Lifecome Biochemistry Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 42.83 | 55.6 | 24.8 | 84.38 | 23.76 | 97.5 |
Cash & Short-Term Investments | 42.83 | 55.6 | 24.8 | 84.38 | 23.76 | 97.5 |
Cash Growth | 290.40% | 124.20% | -70.61% | 255.14% | -75.63% | -49.81% |
Accounts Receivable | 34.26 | 42.64 | 76.83 | 128.42 | 60.06 | 44.86 |
Other Receivables | 6.03 | 9.35 | 17.52 | 59.82 | 2.76 | 19.56 |
Receivables | 40.28 | 51.99 | 94.36 | 188.24 | 62.82 | 64.42 |
Inventory | 99.23 | 95.48 | 95.71 | 201.89 | 89.06 | 61.2 |
Other Current Assets | 4.13 | 4.62 | 1.36 | 3.87 | 330.16 | 4.86 |
Total Current Assets | 186.47 | 207.68 | 216.22 | 478.39 | 505.8 | 227.97 |
Property, Plant & Equipment | 467.29 | 474.44 | 1,062 | 1,150 | 633.54 | 907.87 |
Long-Term Investments | 31.05 | 32.46 | 51.65 | 44.75 | 48.57 | 59.14 |
Goodwill | - | - | - | 61.6 | - | - |
Other Intangible Assets | 20.8 | 21.08 | 125.58 | 132.21 | 31.4 | 40.86 |
Long-Term Deferred Tax Assets | 11.42 | 11.42 | 11.05 | 30.96 | 7.47 | 9.15 |
Long-Term Deferred Charges | - | 0.02 | 12.49 | 0.8 | 0.19 | 2.03 |
Other Long-Term Assets | 4.07 | 1.62 | 12.49 | 66.79 | 12.9 | 11.39 |
Total Assets | 721.08 | 748.71 | 1,492 | 1,965 | 1,240 | 1,258 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Accounts Payable | 98.19 | 102.52 | 315.72 | 310.09 | 136.11 | 167.7 |
Accrued Expenses | 3.94 | 7.2 | 17.12 | 12.56 | 7.95 | 9.79 |
Short-Term Debt | 172.99 | 306.72 | 296.76 | 387.77 | 202.93 | 156.28 |
Current Portion of Long-Term Debt | 99.9 | 170.83 | 479.08 | 85.47 | 41.71 | 37.16 |
Current Portion of Leases | - | - | 4.36 | 1.31 | 0.08 | 0.07 |
Current Income Taxes Payable | 1.19 | - | - | - | - | - |
Current Unearned Revenue | 4.87 | 4.92 | 17.06 | 1.51 | 2.81 | 0.91 |
Other Current Liabilities | 216.1 | 5.05 | 112.6 | 131.61 | 93.54 | 18.42 |
Total Current Liabilities | 597.18 | 597.24 | 1,243 | 930.31 | 485.14 | 390.34 |
Long-Term Debt | - | 30 | 133.92 | 490.25 | 105.88 | 96.99 |
Long-Term Leases | - | - | 35.47 | 121.9 | 45 | 30.69 |
Long-Term Unearned Revenue | 1.64 | 1.94 | 30.02 | 3.47 | 4.32 | 9.63 |
Long-Term Deferred Tax Liabilities | - | - | 3.46 | 4.96 | 0.22 | 8.73 |
Other Long-Term Liabilities | 50 | 54.6 | 70.63 | - | - | - |
Total Liabilities | 648.81 | 683.78 | 1,516 | 1,551 | 640.56 | 536.38 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Common Stock | 155.42 | 155.42 | 155.42 | 155.42 | 155.42 | 155.42 |
Additional Paid-In Capital | 577.19 | 576.51 | 349.47 | 345.46 | 340.47 | 340.47 |
Retained Earnings | -661.98 | -669.15 | -538.36 | -93.5 | 128.32 | 250.26 |
Treasury Stock | - | - | - | - | -32.43 | -32.43 |
Comprehensive Income & Other | 0.41 | 0.41 | 7.2 | 3.91 | 3.91 | 3.91 |
Total Common Equity | 71.03 | 63.18 | -26.27 | 411.29 | 595.69 | 717.63 |
Minority Interest | 1.23 | 1.75 | 1.73 | 2.82 | 3.61 | 4.4 |
Shareholders' Equity | 72.27 | 64.93 | -24.54 | 414.11 | 599.3 | 722.02 |
Total Liabilities & Equity | 721.08 | 748.71 | 1,492 | 1,965 | 1,240 | 1,258 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Total Debt | 272.89 | 507.55 | 949.6 | 1,087 | 395.6 | 321.19 |
Net Cash (Debt) | -230.06 | -451.94 | -924.8 | -1,002 | -371.84 | -223.7 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -1.49 | -2.92 | -5.95 | -6.51 | -2.41 | -1.46 |
Filing Date Shares Outstanding | 156.09 | 155.42 | 155.42 | 155.42 | 153.4 | 153.4 |
Total Common Shares Outstanding | 156.09 | 155.42 | 155.42 | 155.42 | 153.4 | 153.4 |
Working Capital | -410.71 | -389.55 | -1,026 | -451.92 | 20.66 | -162.36 |
Book Value Per Share | 0.46 | 0.41 | -0.17 | 2.65 | 3.88 | 4.68 |
Tangible Book Value | 50.24 | 42.1 | -151.84 | 217.48 | 564.29 | 676.77 |
Tangible Book Value Per Share | 0.32 | 0.27 | -0.98 | 1.40 | 3.68 | 4.41 |
Buildings | - | 388.09 | 543.18 | 479.28 | 406.53 | 206.45 |
Machinery | - | 579.72 | 890.18 | 657.2 | 585.29 | 310.2 |
Construction In Progress | - | 5.52 | 55.9 | 410.78 | 6.2 | 709.64 |